National Health and Medical Research Council (NHMRC) provides assistance to Australian researchers to participate in collaborative research projects with international researchers through both bilateral and multilateral arrangements.
To participate in these schemes, your personal information may need to be disclosed by NHMRC to overseas recipients, generally for the purposes of peer review of the application. You will be advised of this possibility at the time of making your application.
For further information on open calls for research with NHMRC's international partners, refer to Find Funding.
On this page:
- Canadian Institutes of Health Research
- e-ASIA Joint Research Program
- European Research Council
- European Union Framework Programme – Horizon Europe
- European Union Joint Programme – Neurodegenerative Disease Research
- Global Alliance for Chronic Diseases
- Japan Agency for Medical Research and Development
- National Foundation for Science and Technology Development of Vietnam
- National Institute for Health Research
- UK Research and Innovation
Canadian Institutes of Health Research
The Canadian Institutes of Health Research (CIHR) is Canada's federal funding agency for health research. Composed of 13 Institutes, CIHR's mission is to create new scientific knowledge and to enable its translation into improved health, more effective health services and products, and a strengthened Canadian health care system.
NHMRC is partnering with CIHR to support research aiming to improve the understanding of how to design, implement and promote systematic and equitable uptake of evidence-based interventions, to improve population health and well-being in multiple urban environments in Canada and Australia.
NHMRC is providing up to $5 million of funding to support Australian researchers successful through the joint NHMRC-CIHR Healthy Cities Implementation Science Team Grant Scheme 2021 Grant Opportunity.
For further information, refer to the CIHR website.
e-ASIA Joint Research Program
The e-ASIA Joint Research Program (e-ASIA JRP) was established in 2012 to promote innovation and contribute to economic development in the East Asian region. e-ASIA aims to achieve this by supporting international joint research projects, through multilateral processes, as well as promoting researcher interaction through workshops.
NHMRC became a member organisation of the e-ASIA JRP on 2 November 2016.
Find out more about NHMRC's participation in the e-ASIA JRP health research 11th joint call.
For further information, please refer to the e-ASIA JRP website.
e-ASIA JRP is convening a Climate Change and Health Workshop from 6 to 7 September 2022, in Honolulu, Hawaii. The workshop will create an opportunity for researchers to network with the a-ASIA JRP stakeholders.
Registration for the workshop is open to all participants including universities, research institutions and the general public. The workshop will be conducted in a hybrid format, allowing participants to join online or in-person. There is no registration fee, but registration is required to participate either in-person or online.
For further information, visit Climate Change and Health Workshop.
European Research Council
The European Research Council (ERC) is the premier European funding organisation for excellent frontier research. ERC's mission is to encourage the highest quality research in Europe through competitive funding and to support investigator-driven frontier research across all fields, on the basis of scientific excellence.
NHMRC and ERC signed an Implementing Arrangement in October 2018. The arrangement aims to help NHMRC-funded researchers join ERC supported research teams in Europe (for a period when possible) or work remotely during their grant and enables the exchange of ideas and experiences in cutting-edge science.
Project abstracts are now available for the ERC Implementing Arrangements call for Expression of Interest 2020. NHMRC-funded researchers can apply to work with European research teams. For more information about the latest ERC opportunities available, see this list (see download section) and contact ERC for further details.
For further information on the implementation Arrangement, see the FAQs.
If you take up this opportunity let us know by emailing the following details to email@example.com
- ERC team you are collaborating with
- Project name
- Length of collaboration.
European Union Framework Programme – Horizon Europe
- In 2021, the EU implemented its new funding instrument for funding research and development, Horizon Europe, succeeding Horizon 2020 as the EU Framework Programme.
- Horizon Europe facilitates collaboration and strengthens the impact of research and innovation while tackling global challenges.
- The NHMRC‒European Union Collaborative Research Grants scheme supports Australian participation in leading international collaborative research under the EU Framework Programme.
- NHMRC is supporting a number of Horizon Europe 2021 topics to enable Australian researchers to form collaborations with EU partners. Find out more on GrantConnect.
European Union Joint Programme – Neurodegenerative Disease Research
The European Union Joint Programme – Neurodegenerative Disease Research (JPND) is a large global research initiative aimed at tackling the challenge of neurodegenerative diseases. JPND aims to increase coordinated investment between participating countries in research aimed at finding causes, developing cures, and identifying appropriate ways to care for those with neurodegenerative diseases.
The ultimate goal of JPND is to find cures for neurodegenerative diseases and to enable early diagnosis for early targeted treatments.
NHMRC will provide merit-based funding for the Australian-based components of research, where the transnational consortium has been recommended for funding by the JPND under the JPND Call for proposals: Linking pre-diagnosis disturbances of physiological systems to Neurodegenerative Diseases 2021.
For further information, please refer to the JPND website.
Global Alliance for Chronic Diseases
NHMRC is part of the Global Alliance for Chronic Diseases (GACD), a collaboration of major international research funding agencies that support joint funding calls and research capacity building activities to address chronic, non-communicable diseases. NHMRC's CEO is a member of the Board and served as Chair in 2019 and 2020.
The GACD funds, develops and facilitates innovative research collaborations between low, middle and high income countries in the fight against chronic diseases. The alliance focuses on implementation research in low- and middle- income countries (LMICs) and in vulnerable and indigenous populations in high-income countries (HICs).
NHMRC is supporting Australian researchers to participate in the GACD A Life Course Approach to Common Non-communicable Diseases Risk Factor Prevention and Reduction Funding Call. Find out more about the call on GACD: A Life Course Approach to Common NCD Risk Factor Prevention and Reduction and on the GACD website.
The GACD has launched the Implementation Science e-Hub. The e-Hub is a free, virtual platform for knowledge and skill development in implementation research.
For further information, please refer to the GACD website.
Japan Agency for Medical Research and Development
The Japan Agency for Medical Research and Development (AMED) is Japan's national body to promote integrated research and development in the field of medicine, from basic research to clinical trials.
NHMRC and AMED signed a Memorandum of Cooperation in October 2018. NHMRC is working with AMED to advance the development of research cooperation in health and medical research between Japan and Australia.
NHMRC and AMED are currently planning a joint workshop in mid-late 2021 to explore further opportunities for bilateral cooperation.
National Foundation for Science and Technology Development of Vietnam
The National Foundation for Science and Technology Development of Vietnam (NAFOSTED) was established in 2008 and functions as a not-for-profit funder in scientific and technological research projects. NAFOSTED is affiliated with Vietnam's Ministry for Science and Technology.
NHMRC and NAFOSTED signed a Memorandum of Understanding in December 2015 to promote and encourage international health and medical research collaboration between Australia and Vietnam. A joint symposium was held in Hanoi, Vietnam in November 2016. Following this symposium a joint call was developed to support international collaboration between Vietnam and Australia and to generate new knowledge in the three research areas of Infectious Diseases, Maternal/ Child Health, and Public Health.
For outcomes of the NHMRC/ NAFOSTED Joint Call for Collaborative Research please refer to Outcomes of funding rounds.
National Institute for Health Research
The mission of the United Kingdom's (UK) National Institute for Health Research (NIHR) is to maintain a health research system in which the UK National Health Service supports outstanding individuals, working in world class facilities, conducting leading edge research focused on the needs of patients and the public.
In August 2013, NHMRC signed a Memorandum of Understanding with the NIHR to co-fund collaborative clinical trials with both an Australian and UK component.
UK Research and Innovation
The UK's Fund for International Collaboration aims to enhance excellence in research and innovation through global engagement. It focuses on bilateral and multilateral partnerships with global research and development leaders and is administered by UK Research and Innovation (UKRI), which includes the Medical Research Council (MRC) and Economic and Social Research Council (ESRC).
NHMRC and the MRC signed a Memorandum of Understanding in May 2019 to promote and encourage collaboration between Australia and the UK in world-leading prevention research seeking to address the shared burden of non-communicable diseases influenced by the built environment. This led to a joint funding call in 2019: UKRI-NHMRC Built Environment and Prevention Research 2019.
For outcomes of the joint UKRI-NHMRC Built Environment and Prevention Research 2019 Call, please refer to: Outcomes of funding rounds.